Oxidative stress and drugs of abuse: An update

Mini-Reviews in Organic Chemistry

Volumn 10, Issue 4, 2013, Pages 321-334

  Cunha Oliveira, Teresa ^a   Rego, Ana Cristina ^a,b   Oliveira, Catarina R ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Antioxidants; Cytotoxicity; Drugs of abuse; Mitochondria; Monoamines; Oxidative stress

Indexed keywords

ANTIOXIDANTS; DRUG INTERACTIONS; METABOLISM; MITOCHONDRIA; PHYSIOLOGY;

CELL DYSFUNCTION; CELLULARS; DRUG ADDICTION; DRUG OF ABUSE; MITOCHONDRIAS; MONOAMINE; OPIOIDS; OXIDATIVE DAMAGE; OXIDATIVE DEPLETION; OXIDATIVE METABOLISM;

OXIDATIVE STRESS;

EID: 84892954534     PISSN: 1570193X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570193X113106660026     Document Type: Review

References (182)

1. Cunha-Oliveira, T.; Rego, A. C.; Oliveira, C. R. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res. Rev., 2008, 58(1), 192-208.
2. Chawala, S. World Drug Report. United Nations Office on Drugs and Crime; New York; 2011, pp. 8-267.
3. Cunha-Oliveira, T.; Rego, A. C.; Carvalho, F.; Oliveira, C. R. Medical Toxicology of Drugs of Abuse. Chapter 17, In Principles of Addiction-Comprehensive Addictive Behaviors and Disorders, Miller, P., Ed.; Academic Press: 2013; Vol. 1, pp. 159-175.
4. Carvalho, M.; Carmo, H.; Costa, V. M.; Capela, J. P.; Pontes, H.; Remiao, F.; Carvalho, F.; Bastos, M. L. Toxicity of amphetamines: an update. Arch. Toxicol., 2012, 86(8), 1167-1231.
5. Riezzo, I.; Fiore, C.; De, C. D.; Pascale, N.; Neri, M.; Turillazzi, E.; Fineschi, V. Side effects of cocaine abuse: multiorgan toxicity and pathological consequences. Curr. Med. Chem., 2012, 19(33), 5624-5646.
6. Leshner, A. I. Addiction is a brain disease, and it matters. Science, 1997, 278(5335), 45-47.
7. Yamamoto, B. K.; Bankson, M. G. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit. Rev. Neurobiol., 2005, 17(2), 87-117.
8. Cadet, J. L.; Krasnova, I. N.; Jayanthi, S.; Lyles, J. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox. Res., 2007, 11(3-4), 183-202.
9. Wu, C. W.; Ping, Y. H.; Yen, J. C.; Chang, C. Y.; Wang, S. F.; Yeh, C. L.; Chi, C. W.; Lee, H. C. Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol. Appl. Pharmacol., 2007, 220(3), 243-251.
10. Pubill, D.; Chipana, C.; Camins, A.; Pallas, M.; Camarasa, J.; Escubedo, E. Free radical production induced by methamphetamine in rat striatal synaptosomes. Toxicol. Appl. Pharmacol., 2005, 204(1), 57-68.
11. Jimenez, A.; Jorda, E. G.; Verdaguer, E.; Pubill, D.; Sureda, F. X.; Canudas, A. M.; Escubedo, E.; Camarasa, J.; Camins, A.; Pallas, M. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol. Appl. Pharmacol., 2004, 196(2), 223-234.
12. Frey, B. N.; Valvassori, S. S.; Gomes, K. M.; Martins, M. R.; Dal-Pizzol, F.; Kapczinski, F.; Quevedo, J. Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res., 2006, 1097(1), 224-229.
13. Jung, B. D.; Shin, E. J.; Nguyen, X. K.; Jin, C. H.; Bach, J. H.; Park, S. J.; Nah, S. Y.; Wie, M. B.; Bing, G.; Kim, H. C. Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration. Neurochem. Int., 2010, 56(2), 229-244.
14. Fitzmaurice, P. S.; Tong, J.; Yazdanpanah, M.; Liu, P. P.; Kalasinsky, K. S.; Kish, S. J. Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. J. Pharmacol. Exp. Ther., 2006, 319(2), 703-709.
15. Tan, H.; Young, L. T.; Shao, L.; Che, Y.; Honer, W. G.; Wang, J. F. Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex. Int. J. Neuropsychopharmacol., 2012, 15(9), 1275-1285.
16. Acikgoz, O.; Gonenc, S.; Kayatekin, B. M.; Pekcetin, C.; Uysal, N.; Dayi, A.; Semin, I.; Gure, A. The effects of single dose of methamphetamine on lipid peroxidation levels in the rat striatum and prefrontal cortex. Eur. Neuropsychopharmacol., 2000, 10(5), 415-418.
17. Shin, E. J.; Duong, C. X.; Nguyen, X. K.; Li, Z.; Bing, G.; Bach, J. H.; Park, D. H.; Nakayama, K.; Ali, S. F.; Kanthasamy, A. G.; Cadet, J. L.; Nabeshima, T.; Kim, H. C. Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cdelta. Behav. Brain Res., 2012, 232(1), 98-113.
18. da-Rosa, D. D.; Valvassori, S. S.; Steckert, A. V.; Arent, C. O.; Ferreira, C. L.; Lopes-Borges, J.; Varela, R. B.; Mariot, E.; Dal-Pizzol, F.; Andersen, M. L.; Quevedo, J. Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats. J. Neural Transm., 2012, 119(1), 31-38.
19. da-Rosa, D. D.; Valvassori, S. S.; Steckert, A. V.; Ornell, F.; Ferreira, C. L.; Lopes-Borges, J.; Varela, R. B.; Dal-Pizzol, F.; Andersen, M. L.; Quevedo, J. Effects of lithium and valproate on oxidative stress and behavioral changes induced by administration of m-AMPH. Psychiatry Res., 2012, 198(3), 521-526.
20. Lord, K. C.; Shenouda, S. K.; McIlwain, E.; Charalampidis, D.; Lucchesi, P. A.; Varner, K. J. Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovasc. Res., 2010, 87(1), 111-118.
21. Koriem, K. M.; Abdelhamid, A. Z.; Younes, H. F. Caffeic acid Protects Tissue Antioxidants and DNA Content in Methamphetamine Induced Tissue Toxicity in SD Rats. Toxicol. Mech. Methods, 2012, 23(2), 134-143.
22. El-Tawil, O. S.; Abou-Hadeed, A. H.; El-Bab, M. F.; Shalaby, A. A. d-Amphetamine-induced cytotoxicity and oxidative stress in isolated rat hepatocytes. Pathophysiology., 2011, 18(4), 279-285.
23. Shankaran, M.; Yamamoto, B. K.; Gudelsky, G. A. Ascorbic acid prevents 3, 4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse, 2001, 40(1), 55-64.
24. Sprague, J. E.; Nichols, D. E. The monoamine oxidase-B inhibitor L-deprenyl protects against 3, 4-methylenedioxymethamphetamineinduced lipid peroxidation and long-term serotonergic deficits. J. Pharmacol. Exp. Ther., 1995, 273(2), 667-673.
25. Colado, M. I.; O'Shea, E.; Granados, R.; Murray, T. K.; Green, A. R. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine. Br. J. Pharmacol., 1997, 121(5), 889-900.
26. Alves, E.; Summavielle, T.; Alves, C. J.; Gomes-Da-Silva, J.; Barata, J. C.; Fernandes, E.; Bastos, M. L.; Tavares, M. A.; Carvalho, F. Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria. J. Neurosci., 2007, 27(38), 10203-10210.
27. Cerretani, D.; Riezzo, I.; Fiaschi, A. I.; Centini, F.; Giorgi, G.; D'Errico, S.; Fiore, C.; Karch, S. B.; Neri, M.; Pomara, C.; Turillazzi, E.; Fineschi, V. Cardiac oxidative stress determination and myocardial morphology after a single ecstasy (MDMA) administration in a rat model. Int. J. Legal Med., 2008, 122(6), 461-469.
28. Upreti, V. V.; Moon, K. H.; Yu, L. R.; Lee, I. J.; Eddington, N. D.; Ye, X.; Veenstra, T. D.; Song, B. J. Increased oxidativemodifications of cytosolic proteins in 3, 4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver. Proteomics, 2011, 11(2), 202-211.
29. Dietrich, J. B.; Mangeol, A.; Revel, M. O.; Burgun, C.; Aunis, D.; Zwiller, J. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology, 2005, 48(7), 965-974.
30. Bashkatova, V.; Meunier, J.; Vanin, A.; Maurice, T. Nitric oxide and oxidative stress in the brain of rats exposed in utero to cocaine. Ann. NY Acad. Sci., 2006, 1074, 632-642.
31. Poon, H. F.; Abdullah, L.; Mullan, M. A.; Mullan, M. J.; Crawford, F. C. Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells. Neurochem. Int., 2007, 50(1), 69-73.
32. Numa, R.; Kohen, R.; Poltyrev, T.; Yaka, R. Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization. Neuroscience, 2008, 155(3), 649-658.
33. Pomierny-Chamiolo, L.; Moniczewski, A.; Wydra, K.; Suder, A.; Filip, M. Oxidative Stress Biomarkers in Some Rat Brain Structures and Peripheral Organs Underwent Cocaine. Neurotox. Res., 2012, 23(1), 92-102.
34. Devi, B. G.; Chan, A. W. Effect of cocaine on cardiac biochemical functions. J. Cardiovasc. Pharmacol., 1999, 33(1), 1-6.
35. Darke, S.; Kaye, S.; Duflou, J. Comparative cardiac pathology among deaths due to cocaine toxicity, opioid toxicity and non-drugrelated causes. Addiction, 2006, 101(12), 1771-1777.
36. Afonso, L.; Mohammad, T.; Thatai, D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am. J. Cardiol., 2007, 100(6), 1040-1043.
37. Pacifici, R.; Fiaschi, A. I.; Micheli, L.; Centini, F.; Giorgi, G.; Zuccaro, P.; Pichini, S.; Di, C. S.; Bacosi, A.; Cerretani, D. Immunosuppression and oxidative stress induced by acute and chronic exposure to cocaine in rat. Int. Immunopharmacol., 2003, 3(4), 581-592.
38. Li, J. M.; Gall, N. P.; Grieve, D. J.; Chen, M.; Shah, A. M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension, 2002, 40(4), 477-484.
39. Fan, L.; Sawbridge, D.; George, V.; Teng, L.; Bailey, A.; Kitchen, I.; Li, J. M. Chronic cocaine-induced cardiac oxidative stress and mitogen-activated protein kinase activation: the role of Nox2 oxidase. J. Pharmacol. Exp. Ther., 2009, 328(1), 99-106.
40. Ozmen, I.; Naziroglu, M.; Alici, H. A.; Sahin, F.; Cengiz, M.; Eren, I. Spinal morphine administration reduces the fatty acid contents in spinal cord and brain by increasing oxidative stress. Neurochem. Res., 2007, 32(1), 19-25.
41. Qiusheng, Z.; Yuntao, Z.; Rongliang, Z.; Dean, G.; Changling, L. Effects of verbascoside and luteolin on oxidative damage in brain of heroin treated mice. Pharmazie, 2005, 60(7), 539-543.
42. Xu, B.; Wang, Z.; Li, G.; Li, B.; Lin, H.; Zheng, R.; Zheng, Q. Heroin-administered mice involved in oxidative stress and exogenous antioxidant-alleviated withdrawal syndrome. Basic Clin. Pharmacol. Toxicol., 2006, 99(2), 153-161.
43. Pan, J.; Zhang, Q.; Zhang, Y.; Ouyang, Z.; Zheng, Q.; Zheng, R. Oxidative stress in heroin administered mice and natural antioxidants protection. Life Sci., 2005, 77(2), 183-193.
44. Pereska, Z.; Dejanova, B.; Bozinovska, C.; Petkovska, L. Prooxidative/antioxidative homeostasis in heroin addiction and detoxification. Bratisl. Lek. Listy, 2007, 108(9), 393-398.
45. Cemek, M.; Buyukokuroglu, M. E.; Hazman, O.; Konuk, M.; Bulut, S.; Birdane, Y. O. The roles of melatonin and vitamin E plus selenium in prevention of oxidative stress induced by naloxoneprecipitated withdrawal in heroin-addicted rats. Biol. Trace Elem. Res., 2011, 142(1), 55-66.
46. Cunha-Oliveira, T.; Rego, A. C.; Morgadinho, M. T.; Macedo, T.; Oliveira, C. R. Differential cytotoxic responses of PC12 cells chronically exposed to psychostimulants or to hydrogen peroxide. Toxicology, 2006, 217(1), 54-62.
47. Mirecki, A.; Fitzmaurice, P.; Ang, L.; Kalasinsky, K. S.; Peretti, F. J.; Aiken, S. S.; Wickham, D. J.; Sherwin, A.; Nobrega, J. N.; Forman, H. J.; Kish, S. J. Brain antioxidant systems in human methamphetamine users. J. Neurochem., 2004, 89(6), 1396-1408.
48. Frey, B. N.; Valvassori, S. S.; Reus, G. Z.; Martins, M. R.; Petronilho, F. C.; Bardini, K.; Dal-Pizzol, F.; Kapczinski, F.; Quevedo, J. Changes in Antioxidant Defense Enzymes after D-: amphetamine Exposure: Implications as an Animal Model of Mania. Neurochem. Res., 2006, 31(5), 699-703.
49. Carvalho, F.; Fernandes, E.; Remiao, F.; Gomes-Da-Silva, J.; Tavares, M. A.; Bastos, M. D. Adaptative response of antioxidant enzymes in different areas of rat brain after repeated d-amphetamine administration. Addict. Biol., 2001, 6(3), 213-221.
50. Carvalho, F. D.; Bastos, M. L.; Timbrell, J. A. Depletion of total nonprotein sulphydryl groups in mouse tissues after administration of d-amphetamine. Toxicology, 1993, 83(1-3), 31-40.
51. Carvalho, F.; Remiao, F.; Amado, F.; Domingues, P.; Correia, A. J.; Bastos, M. L. d-Amphetamine interaction with glutathione in freshly isolated rat hepatocytes. Chem. Res. Toxicol., 1996, 9(6), 1031-1036.
52. Carvalho, F.; Remiao, F.; Soares, M. E.; Catarino, R.; Queiroz, G.; Bastos, M. L. d-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes. Arch. Toxicol., 1997, 71(7), 429-436.
53. Zhang, X.; Banerjee, A.; Banks, W. A.; Ercal, N. N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res., 2009, 1275, 87-95.
54. Capela, J. P.; Fernandes, E.; Remiao, F.; Bastos, M. L.; Meisel, A.; Carvalho, F. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons. Neurotoxicology, 2007, 28(4), 868-875.
55. Frenzilli, G.; Ferrucci, M.; Giorgi, F. S.; Blandini, F.; Nigro, M.; Ruggieri, S.; Murri, L.; Paparelli, A.; Fornai, F. DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3, 4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations. Behav. Pharmacol., 2007, 18(5-6), 471-481.
56. Jayanthi, S.; Ladenheim, B.; Andrews, A. M.; Cadet, J. L. Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy). Neuroscience, 1999, 91(4), 1379-1387.
57. Cerretani, D.; Bello, S.; Cantatore, S.; Fiaschi, A. I.; Montefrancesco, G.; Neri, M.; Pomara, C.; Riezzo, I.; Fiore, C.; Bonsignore, A.; Turillazzi, E.; Fineschi, V. Acute administration of 3, 4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFalpha-mediated apoptosis in rat liver. Pharmacol. Res., 2011, 64(5), 517-527.
58. Macedo, D. S.; de Vasconcelos, S. M.; dos Santos, R. S.; Aguiar, L. M.; Lima, V. T.; Viana, G. S.; de Sousa, F. C. Cocaine alters catalase activity in prefrontal cortex and striatum of mice. Neurosci. Lett., 2005, 387(1), 53-56.
59. Lipton, J. W.; Gyawali, S.; Borys, E. D.; Koprich, J. B.; Ptaszny, M.; McGuire, S. O. Prenatal cocaine administration increases glutathione and alpha-tocopherol oxidation in fetal rat brain. Brain Res. Dev. Brain Res., 2003, 147(1-2), 77-84.
60. Muriach, M.; Lopez-Pedrajas, R.; Barcia, J. M.; Sanchez-Villarejo, M. V.; Almansa, I.; Romero, F. J. Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. J. Neurochem., 2010, 114(3), 675-684.
61. Numa, R.; Baron, M.; Kohen, R.; Yaka, R. Tempol attenuates cocaine-induced death of PC12 cells through decreased oxidative damage. Eur. J. Pharmacol., 2011, 650(1), 157-162.
62. Fineschi, V.; Baroldi, G.; Centini, F.; Cerretani, D.; Fiaschi, A. I.; Micheli, L.; Parolini, M.; Turillazzi, E.; Giorgi, G. Markers of cardiac oxidative stress and altered morphology after intraperitoneal cocaine injection in a rat model. Int. J. Legal Med., 2001, 114(6), 323-330.
63. Devi, B. G.; Chan, A. W. Impairment of mitochondrial respiration and electron transport chain enzymes during cocaine-induced hepatic injury. Life Sci, 1997, 60(11), 849-855.
64. Devi, B. G.; Chan, A. W. Cocaine-induced peroxidative stress in rat liver: antioxidant enzymes and mitochondria. J. Pharmacol. Exp. Ther., 1996, 279(1), 359-366.
65. Boess, F.; Ndikum-Moffor, F. M.; Boelsterli, U. A.; Roberts, S. M. Effects of cocaine and its oxidative metabolites on mitochondrial respiration and generation of reactive oxygen species. Biochem. Pharmacol., 2000, 60(5), 615-623.
66. Kovacic, P. Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. Med. Hypotheses, 2005, 64(2), 350-356.
67. Moritz, F.; Monteil, C.; Isabelle, M.; Bauer, F.; Renet, S.; Mulder, P.; Richard, V.; Thuillez, C. Role of reactive oxygen species in cocaine-induced cardiac dysfunction. Cardiovasc. Res., 2003, 59(4), 834-843.
68. Diez-Fernandez, C.; Zaragoza, A.; Alvarez, A. M.; Cascales, M. Cocaine cytotoxicity in hepatocyte cultures from phenobarbitalinduced rats: involvement of reactive oxygen species and expression of antioxidant defense systems. Biochem. Pharmacol., 1999, 58(5), 797-805.
69. Zaragoza, A.; Diez-Fernandez, C.; Alvarez, A. M.; Andres, D.; Cascales, M. Effect of N-acetylcysteine and deferoxamine on endogenous antioxidant defense system gene expression in a rat hepatocyte model of cocaine cytotoxicity. Biochim. Biophys. Acta, 2000, 1496(2-3), 183-195.
70. Valente, M. J.; Henrique, R.; Vilas-Boas, V.; Silva, R.; Bastos, M. L.; Carvalho, F.; Guedes de, P. P.; Carvalho, M. Cocaineinduced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells. Arch. Toxicol., 2012, 86(2), 249-261.
71. Zhou, J.; Li, Y.; Yan, G.; Bu, Q.; Lv, L.; Yang, Y.; Zhao, J.; Shao, X.; Deng, Y.; Zhu, R.; Zhao, Y.; Cen, X. Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress. Neurotox. Res., 2011, 20(4), 334-342.
72. Guzman, D. C.; Vazquez, I. E.; Brizuela, N. O.; Alvarez, R. G.; Mejia, G. B.; Garcia, E. H.; Santamaria, D.; de Apreza, M. R.; Olguin, H. J. Assessment of oxidative damage induced by acute doses of morphine sulfate in postnatal and adult rat brain. Neurochem. Res., 2006, 31(4), 549-554.
73. Benedi, J.; Arroyo, R.; Romero, C.; Martin-Aragon, S.; Villar, A. M. Antioxidant properties and protective effects of a standardized extract of Hypericum perforatum on hydrogen peroxideinduced oxidative damage in PC12 cells. Life Sci., 2004, 75(10), 1263-1276.
74. Jang, J. H.; Surh, Y. J. Possible role of NF-kappaB in Bcl-X(L) protection against hydrogen peroxide-induced PC12 cell death. Redox Rep., 2004, 9(6), 343-348.
75. Wiese, A. G.; Pacifici, R. E.; Davies, K. J. Transient adaptation of oxidative stress in mammalian cells. Arch. Biochem. Biophys., 1995, 318(1), 231-240.
76. Davies, K. J. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB. Life, 1999, 48(1), 41-47.
77. El, A. A.; Zigmond, M. J. Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic study. PLoS. One., 2011, 6(10), e24722.
78. Uys, J. D.; Knackstedt, L.; Hurt, P.; Tew, K. D.; Manevich, Y.; Hutchens, S.; Townsend, D. M.; Kalivas, P. W. Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity. Neuropsychopharmacology, 2011, 36(12), 2551-2560.
79. Cunha-Oliveira, T.; Rego, A. C.; Morgadinho, M. T.; Macedo, T.; Oliveira, C. R. Chronic effects of heroin and hydrogen peroxide in PC12 cells. Coimb. Méd. V Ser., 2006, 2(1), 21-29.
80. Green, A. R.; Mechan, A. O.; Elliott, J. M.; O'Shea, E.; Colado, M. I. The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev., 2003, 55(3), 463-508.
81. Milhazes, N.; Cunha-Oliveira, T.; Martins, P.; Garrido, J.; Oliveira, C.; Rego, A. C.; Borges, F. Synthesis and cytotoxic profile of 3, 4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship. Chem. Res. Toxicol., 2006, 19(10), 1294-1304.
82. Barbosa, D. J.; Capela, J. P.; Oliveira, J. M.; Silva, R.; Ferreira, L. M.; Siopa, F.; Branco, P. S.; Fernandes, E.; Duarte, J. A.; de Lourdes, B. M.; Carvalho, F. Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes. Br. J. Pharmacol., 2012, 165(4b), 1017-1033.
83. Capela, J. P.; Macedo, C.; Branco, P. S.; Ferreira, L. M.; Lobo, A. M.; Fernandes, E.; Remiao, F.; Bastos, M. L.; Dirnagl, U.; Meisel, A.; Carvalho, F. Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience, 2007, 146(4), 1743-1757.
84. Carvalho, M.; Remiao, F.; Milhazes, N.; Borges, F.; Fernandes, E.; Monteiro, M. C.; Goncalves, M. J.; Seabra, V.; Amado, F.; Carvalho, F.; Bastos, M. L. Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro. Chem. Res. Toxicol., 2004, 17(5), 623-632.
85. Shenouda, S. K.; Varner, K. J.; Carvalho, F.; Lucchesi, P. A. Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes. Cardiovasc. Toxicol., 2009, 9(1), 30-38.
86. Carvalho, M.; Remiao, F.; Milhazes, N.; Borges, F.; Fernandes, E.; Carvalho, F.; Bastos, M. L. The toxicity of N-methyl-alphamethyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Toxicology, 2004, 200(2-3), 193-203.
87. Carvalho, M.; Milhazes, N.; Remiao, F.; Borges, F.; Fernandes, E.; Amado, F.; Monks, T. J.; Carvalho, F.; Bastos, M. L. Hepatotoxicity of 3, 4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch. Toxicol., 2004, 78(1), 16-24.
88. Boelsterli, U. A.; Wolf, A.; Goldlin, C. Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite, cocaethylene, in rat hepatocytes. Hepatology, 1993, 18(5), 1154-1161.
89. Ndikum-Moffor, F. M.; Schoeb, T. R.; Roberts, S. M. Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine. J. Pharmacol. Exp. Ther., 1998, 284(1), 413-419.
90. Sulzer, D. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron, 2011, 69(4), 628-649.
91. Sitte, H. H.; Huck, S.; Reither, H.; Boehm, S.; Singer, E. A.; Pifl, C. Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J. Neurochem., 1998, 71(3), 1289-1297.
92. Jones, S. R.; Joseph, J. D.; Barak, L. S.; Caron, M. G.; Wightman, R. M. Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem., 1999, 73(6), 2406-2414.
93. Nestler, E. J. Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci., 2004, 25(4), 210-218.
94. Graham, D. G.; Tiffany, S. M.; Bell, W. R., Jr.; Gutknecht, W. F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol., 1978, 14(4), 644-653.
95. McLaughlin, B. A.; Nelson, D.; Erecinska, M.; Chesselet, M. F. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J. Neurochem., 1998, 70(6), 2406-2415.
96. Hastings, T. G.; Lewis, D. A.; Zigmond, M. J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U. S. A, 1996, 93(5), 1956-1961.
97. Fornai, F.; Giorgi, F. S.; Bassi, L.; Ferrucci, M.; Alessandri, M. G.; Corsini, G. U. Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment. Brain Res., 2000, 861(1), 126-134.
98. Youdim, M. B.; Edmondson, D.; Tipton, K. F. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci., 2006, 7(4), 295-309.
99. Shih, J. C.; Chen, K.; Ridd, M. J. Monoamine oxidase: from genes to behavior. Annu. Rev. Neurosci., 1999, 22, 197-217.
100. Marchitti, S. A.; Deitrich, R. A.; Vasiliou, V. Neurotoxicity and metabolism of the catecholamine-derived 3, 4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol. Rev., 2007, 59(2), 125-150.
101. Hastings, T. G. The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease. J. Bioenerg. Biomembr., 2009, 41(6), 469-472.
102. Jones, D. C.; Gunasekar, P. G.; Borowitz, J. L.; Isom, G. E. Dopamine-induced apoptosis is mediated by oxidative stress and Is enhanced by cyanide in differentiated PC12 cells. J. Neurochem., 2000, 74(6), 2296-2304.
103. Gibb, J. W.; Kogan, F. J. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch. Pharmacol., 1979, 310(2), 185-187.
104. Florin, S. M.; Kuczenski, R.; Segal, D. S. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res., 1994, 654(1), 53-62.
105. Sulzer, D.; Sonders, M. S.; Poulsen, N. W.; Galli, A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol., 2005, 75(6), 406-433.
106. Amato, J. L.; Bankson, M. G.; Yamamoto, B. K. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor. Neuropsychopharmacology, 2007, 32(4), 946-954.
107. Shankaran, M.; Yamamoto, B. K.; Gudelsky, G. A. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3, 4-methylenedioxymethamphetamine. Eur. J. Pharmacol., 1999, 385(2-3), 103-110.
108. Capela, J. P.; Carmo, H.; Remiao, F.; Bastos, M. L.; Meisel, A.; Carvalho, F. Molecular and cellular mechanisms of ecstasyinduced neurotoxicity: an overview. Mol. Neurobiol., 2009, 39(3), 210-271.
109. Vongpatanasin, W.; Mansour, Y.; Chavoshan, B.; Arbique, D.; Victor, R. G. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation, 1999, 100(5), 497-502.
110. Egashira, K.; Morgan, K. G.; Morgan, J. P. Effects of cocaine on excitation-contraction coupling of aortic smooth muscle from the ferret. J. Clin. Invest, 1991, 87(4), 1322-1328.
111. Brandes, R. P.; Kreuzer, J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc. Res., 2005, 65(1), 16-27.
112. Landmesser, U.; Dikalov, S.; Price, S. R.; McCann, L.; Fukai, T.; Holland, S. M.; Mitch, W. E.; Harrison, D. G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest., 2003, 111(8), 1201-1209.
113. Behonick, G. S.; Novak, M. J.; Nealley, E. W.; Baskin, S. I. Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). J. Appl. Toxicol., 2001, 21 (Suppl 1), S15-S22.
114. Brown, J. M.; Yamamoto, B. K. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol. Ther., 2003, 99(1), 45-53.
115. Cadet, J. L.; Brannock, C. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int., 1998, 32(2), 117-131.
116. Burrows, K. B.; Gudelsky, G.; Yamamoto, B. K. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3, 4-methylenedioxymethamphetamine administration. Eur. J. Pharmacol., 2000, 398(1), 11-18.
117. Brown, J. M.; Quinton, M. S.; Yamamoto, B. K. Methamphetamineinduced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite. J. Neurochem., 2005, 95(2), 429-436.
118. Shiba, T.; Yamato, M.; Kudo, W.; Watanabe, T.; Utsumi, H.; Yamada, K. In vivo imaging of mitochondrial function in methamphetamine-treated rats. Neuroimage., 2011, 57(3), 866-872.
119. Cunha-Oliveira, T.; Rego, A. C.; Cardoso, S. M.; Borges, F.; Swerdlow, R. H.; Macedo, T.; de Oliveira, C. R. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res., 2006, 1089(1), 44-54.
120. Davidson, C.; Gow, A. J.; Lee, T. H.; Ellinwood, E. H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Rev., 2001, 36(1), 1-22.
121. Sulzer, D.; Rayport, S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron, 1990, 5(6), 797-808.
122. Tian, C.; Murrin, L. C.; Zheng, J. C. Mitochondrial fragmentation is involved in methamphetamine-induced cell death in rat hippocampal neural progenitor cells. PLoS One, 2009, 4(5), e5546.
123. Li, F. C.; Yen, J. C.; Chan, S. H.; Chang, A. Y. Bioenergetics failure and oxidative stress in brain stem mediates cardiovascular collapse associated with fatal methamphetamine intoxication. PLoS One, 2012, 7(1), e30589.
124. Moon, K. H.; Upreti, V. V.; Yu, L. R.; Lee, I. J.; Ye, X.; Eddington, N. D.; Veenstra, T. D.; Song, B. J. Mechanism of 3, 4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver. Proteomics, 2008, 8(18), 3906-3918.
125. Nakagawa, Y.; Suzuki, T.; Tayama, S.; Ishii, H.; Ogata, A. Cytotoxic effects of 3, 4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes. Arch. Toxicol., 2009, 83(1), 69-80.
126. Beitia, G.; Cobreros, A.; Sainz, L.; Cenarruzabeitia, E. 3, 4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes. Liver, 1999, 19(3), 234-241.
127. Fisher, A. A.; Labenski, M. T.; Malladi, S.; Gokhale, V.; Bowen, M. E.; Milleron, R. S.; Bratton, S. B.; Monks, T. J.; Lau, S. S. Quinone electrophiles selectively adduct "electrophile binding motifs" within cytochrome c. Biochemistry, 2007, 46(39), 11090-11100.
128. Cunha-Oliveira, T.; Rego, A. C.; Garrido, J.; Borges, F.; Macedo, T.; Oliveira, C. R. Neurotoxicity of heroin-cocaine combinations in rat cortical neurons. Toxicology, 2010, 276(1), 11-17.
129. Dietrich, J. B.; Poirier, R.; Aunis, D.; Zwiller, J. Cocaine downregulates the expression of the mitochondrial genome in rat brain. Ann. NY Acad. Sci., 2004, 1025, 345-350.
130. Yuan, C.; Acosta, D., Jr. Effect of cocaine on mitochondrial electron transport chain evaluated in primary cultures of neonatal rat myocardial cells and in isolated mitochondrial preparations. Drug Chem. Toxicol., 2000, 23(2), 339-348.
131. Heard, K.; Palmer, R.; Zahniser, N. R. Mechanisms of acute cocaine toxicity. Open Pharmacol. J., 2008, 2(9), 70-78.
132. Lehrmann, E.; Oyler, J.; Vawter, M. P.; Hyde, T. M.; Kolachana, B.; Kleinman, J. E.; Huestis, M. A.; Becker, K. G.; Freed, W. J. Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics. J., 2003, 3(1), 27-40.
133. Alvaro-Bartolome, M.; La, H. R.; Callado, L. F.; Meana, J. J.; Garcia-Sevilla, J. A. Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats. Neuroscience, 2011, 196, 1-15.
134. Masini, A.; Gallesi, D.; Giovannini, F.; Trenti, T.; Ceccarelli, D. Membrane potential of hepatic mitochondria after acute cocaine administration in rats--the role of mitochondrial reduced glutathione. Hepatology, 1997, 25(2), 385-390.
135. Cunha-Oliveira, T.; Silva, L.; Silva, A. M.; Moreno, A. J.; Oliveira, C. R.; Santos, M. S. Acute effects of cocaine, morphine and their combination on bioenergetic function and susceptibility to oxidative stress of rat liver mitochondria. Life Sci., 2013, 92(24-26), 1157-1164.
136. Cunha-Oliveira, T.; Silva, L.; Silva, A. M.; Moreno, A. J.; Oliveira, C. R.; Santos, M. S. Mitochondrial complex I dysfunction induced by cocaine and cocaine plus morphine in brain and liver mitochondria. Toxicol. Lett., 2013, 219(3), 298-306.
137. Vergeade, A.; Mulder, P.; Vendeville-Dehaudt, C.; Estour, F.; Fortin, D.; Ventura-Clapier, R.; Thuillez, C.; Monteil, C. Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: Prevention by the targeted antioxidant MitoQ. Free Radic. Biol. Med., 2010, 49(5), 748-756.
138. Vergeade, A.; Mulder, P.; Vendeville, C.; Ventura-Clapier, R.; Thuillez, C.; Monteil, C. Xanthine Oxidase Contributes to Mitochondrial ROS Generation in an Experimental Model of Cocaine-Induced Diastolic Dysfunction. J. Cardiovasc. Pharmacol., 2012, 60(6), 538-543.
139. Sinha-Hikim, I.; Shen, R.; Nzenwa, I.; Gelfand, R.; Mahata, S. K.; Sinha-Hikim, A. P. Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure. Apoptosis, 2011, 16(6), 563-573.
140. Cunha-Oliveira, T.; Rego, A. C.; Garrido, J.; Borges, F.; Macedo, T.; Oliveira, C. R. Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons. J. Neurochem., 2007, 101(2), 543-554.
141. Tan, M.; Li, Z.; Ma, S.; Luo, J.; Xu, S.; Lu, A.; Gan, W.; Su, P.; Lin, H.; Li, S.; Lai, B. Heroin activates Bim via c-Jun N-terminal kinase/c-Jun pathway to mediate neuronal apoptosis. Neuroscience, 2012, 233, 1-8.
142. Lin, X.; Wang, Y. J.; Li, Q.; Hou, Y. Y.; Hong, M. H.; Cao, Y. L.; Chi, Z. Q.; Liu, J. G. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinasemediated activation of mitochondria-dependent pathway. FEBS J., 2009, 276(7), 2022-2036.
143. Uys, J. D.; Reissner, K. J. Glutamatergic neuroplasticity in cocaine addiction. Prog. Mol. Biol. Transl. Sci., 2011, 98, 367-400.
144. Tzschentke, T. M.; Schmidt, W. J. Glutamatergic mechanisms in addiction. Mol. Psychiatry, 2003, 8(4), 373-382.
145. Wickens, J. R.; Horvitz, J. C.; Costa, R. M.; Killcross, S. Dopaminergic mechanisms in actions and habits. J. Neurosci., 2007, 27(31), 8181-8183.
146. Wolf, M. E.; Xue, C. J.; Li, Y.; Wavak, D. Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species. J. Neurochem., 2000, 75(4), 1634-1644.
147. Reid, M. S.; Hsu, K., Jr.; Berger, S. P. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse, 1997, 27(2), 95-105.
148. Williams, J. M.; Steketee, J. D. Cocaine increases medial prefrontal cortical glutamate overflow in cocaine-sensitized rats: a time course study. Eur. J. Neurosci., 2004, 20(6), 1639-1646.
149. Rego, A. C.; Oliveira, C. R. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem. Res., 2003, 28(10), 1563-1574.
150. Beal, M. F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol., 1992, 31(2), 119-130.
151. McCormack, J. G.; Halestrap, A. P.; Denton, R. M. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol. Rev., 1990, 70(2), 391-425.
152. Kowaltowski, A. J.; de Souza-Pinto, N. C.; Castilho, R. F.; Vercesi, A. E. Mitochondria and reactive oxygen species. Free Radic. Biol. Med., 2009, 47(4), 333-343.
153. Yeh, G. C.; Chen, J. C.; Tsai, H. C.; Wu, H. H.; Lin, C. Y.; Hsu, P. C.; Peng, Y. C. Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex. J. Pharmacol. Exp. Ther., 2002, 300(3), 1008-1016.
154. Sonsalla, P. K. The role of N-methyl-D-aspartate receptors in dopaminergic neuropathology produced by the amphetamines. Drug Alcohol Depend., 1995, 37(2), 101-105.
155. Krasnova, I. N.; Cadet, J. L. Methamphetamine toxicity and messengers of death. Brain Res. Rev., 2009, 60(2), 379-407.
156. Quinton, M. S.; Yamamoto, B. K. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J., 2006, 8(2), E337-E347.
157. Yamamoto, B. K.; Raudensky, J. The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. J. Neuroimmune Pharmacol., 2008, 3(4), 203-217.
158. Fiaschi, A. I.; Cerretani, D. Causes and effects of cellular oxidative stress as a result of MDMA abuse. Curr. Pharm. Biotechnol., 2010, 11(5), 444-452.
159. Dykens, J. A.; Stern, A.; Trenkner, E. Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J. Neurochem., 1987, 49(4), 1222-1228.
160. Domingues, A.; Cunha-Oliveira, T.; Laco, M. L.; Macedo, T. R.; Oliveira, C. R.; Rego, A. C. Expression of NR1/NR2B N-methyl-Daspartate receptors enhances heroin toxicity in HEK293 cells. Ann NY Acad. Sci., 2006, 1074, 458-465.
161. Cadet, J. L.; Krasnova, I. N. Molecular bases of methamphetamineinduced neurodegeneration. Int. Rev. Neurobiol., 2009, 88, 101-119.
162. Thomas, D. M.; Dowgiert, J.; Geddes, T. J.; Francescutti-Verbeem, D.; Liu, X.; Kuhn, D. M. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci. Lett., 2004, 367(3), 349-354.
163. Sekine, Y.; Ouchi, Y.; Sugihara, G.; Takei, N.; Yoshikawa, E.; Nakamura, K.; Iwata, Y.; Tsuchiya, K. J.; Suda, S.; Suzuki, K.; Kawai, M.; Takebayashi, K.; Yamamoto, S.; Matsuzaki, H.; Ueki, T.; Mori, N.; Gold, M. S.; Cadet, J. L. Methamphetamine causes microglial activation in the brains of human abusers. J. Neurosci., 2008, 28(22), 5756-5761.
164. LaVoie, M. J.; Card, J. P.; Hastings, T. G. Microglial activation precedes dopamine terminal pathology in methamphetamineinduced neurotoxicity. Exp. Neurol., 2004, 187(1), 47-57.
165. Goncalves, J.; Ribeiro, C. F.; Malva, J. O.; Silva, A. P. Protective role of neuropeptide Y Y(2) receptors in cell death and microglial response following methamphetamine injury. Eur. J. Neurosci., 2012, 36(9), 3173-3183.
166. Goncalves, J.; Baptista, S.; Martins, T.; Milhazes, N.; Borges, F.; Ribeiro, C. F.; Malva, J. O.; Silva, A. P. Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur. J. Neurosci., 2010, 31(2), 315-326.
167. Kuhn, D. M.; Francescutti-Verbeem, D. M.; Thomas, D. M. Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage. Ann. NY Acad. Sci., 2006, 1074, 31-41.
168. Islam, M. N.; Jesmine, K.; Kong Sn, M. A.; Hasnan, J. Histopathological studies of cardiac lesions after long term administration of methamphetamine in high dosage--Part II. Leg. Med., 2009, 11 (Suppl. 1), S147-S150.
169. Costa, V. M.; Carvalho, F.; Bastos, M. L.; Carvalho, R. A.; Carvalho, M.; Remiao, F. Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases. Curr. Med. Chem., 2011, 18(15), 2272-2314.
170. Varner, K. J.; Ogden, B. A.; Delcarpio, J.; Meleg-Smith, S. Cardiovascular responses elicited by the "binge" administration of methamphetamine. J. Pharmacol. Exp. Ther., 2002, 301(1), 152-159.
171. Flanagan, S. W.; Moseley, P. L.; Buettner, G. R. Increased flux of free radicals in cells subjected to hyperthermia: detection by electron paramagnetic resonance spin trapping. FEBS Lett., 1998, 431(2), 285-286.
172. Skibba, J. L.; Stadnicka, A.; Kalbfleisch, J. H.; Powers, R. H. Effects of hyperthermia on xanthine oxidase activity and glutathione levels in the perfused rat liver. J. Biochem. Toxicol., 1989, 4(2), 119-125.
173. O'Shea, E.; Escobedo, I.; Orio, L.; Sanchez, V.; Navarro, M.; Green, A. R.; Colado, M. I. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology, 2005, 30(7), 1312-1323.
174. Fleckenstein, A. E.; Wilkins, D. G.; Gibb, J. W.; Hanson, G. R. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Ther., 1997, 283(1), 281-285.
175. Colado, M. I.; O'Shea, E.; Esteban, B.; Granados, R.; Green, A. R. In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism. Neuropharmacology, 1999, 38(2), 307-314.
176. Capela, J. P.; Ruscher, K.; Lautenschlager, M.; Freyer, D.; Dirnagl, U.; Gaio, A. R.; Bastos, M. L.; Meisel, A.; Carvalho, F. Ecstasyinduced cell death in cortical neuronal cultures is serotonin 2Areceptor-dependent and potentiated under hyperthermia. Neuroscience, 2006, 139(3), 1069-1081.
177. Carvalho, M.; Carvalho, F.; Bastos, M. L. Is hyperthermia the triggering factor for hepatotoxicity induced by 3, 4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes. Arch. Toxicol., 2001, 74(12), 789-793.
178. Upreti, V. V.; Eddington, N. D.; Moon, K. H.; Song, B. J.; Lee, I. J. Drug interaction between ethanol and 3, 4-methylenedioxymethamphetamine ("ecstasy"). Toxicol. Lett., 2009, 188(2), 167-172.
179. Pontes, H.; Duarte, J. A.; de Pinho, P. G.; Soares, M. E.; Fernandes, E.; Dinis-Oliveira, R. J.; Sousa, C.; Silva, R.; Carmo, H.; Casal, S.; Remiao, F.; Carvalho, F.; Bastos, M. L. Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice. Toxicology, 2008, 252(1-3), 64-71.
180. Pontes, H.; Sousa, C.; Silva, R.; Fernandes, E.; Carmo, H.; Remiao, F.; Carvalho, F.; Bastos, M. L. Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes. Toxicology, 2008, 254(1-2), 42-50.
181. Song, B. J.; Moon, K. H.; Upreti, V. V.; Eddington, N. D.; Lee, I. J. Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage. Curr. Pharm. Biotechnol., 2010, 11(5), 434-443.
182. Venkatesan, A.; Uzasci, L.; Chen, Z.; Rajbhandari, L.; Anderson, C.; Lee, M. H.; Bianchet, M. A.; Cotter, R.; Song, H.; Nath, A. Impairment of adult hippocampal neural progenitor proliferation by methamphetamine: role for nitrotyrosination. Mol. Brain, 2011, 4, 28.